No records
|
506 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Tgf-?-induced tmepai promotes epithelial? mesenchymal transition in doxorubicin-treated triple-negative breast cancer cells via smad3 and pi3k/akt pathway alteration |
Wardhani B.W.K., Louisa M., Watanabe Y., Setiabudy R., Kato M. |
Breast Cancer: Targets and Therapy |
|
Q2 |
|
|
627 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The use of Urinary Lipoarabinomannan (LAM) as a Rapid Diagnostic Test for Adult Pulmonary Tuberculosis in HIV-Positive Patients: An Evidence-based Case Report |
Kusumawardani A., Yanfaunnas A.M., Supandi D.P., Inggita R.A.M., Andayani N.G.A.A.P.T., Louisa M., Soetikno V., Burhan E. |
Journal of International Dental and Medical Research |
|
Q3 |
|
|
633 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Efficacy of adjuvant intrastromal and combination of intrastromal and intracameral voriconazole in aspergillus fumigatus-induced moderate fungal keratitis in rabbits |
Sarika D.T., Louisa M., Rozaliyani A., Evelina, Susiyanti M. |
Medical Journal of Indonesia |
|
Q4 |
|
|
651 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The future potential of Annona muricata L. extract and its bioactive compounds as radiation sensitizing agents: Proposed mechanisms based on a systematic review |
Wijaya D.A., Louisa M., Wibowo H., Taslim A., Permata T.B.M., Handoko, Nuryadi E., Kodrat H., Gondhowiardjo S.A. |
Journal of HerbMed Pharmacology |
|
Q3 |
|
|
669 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Flt3-itd mutation and flt3 ligand plasma level were not associated with one-year survival of Indonesian acute myeloid leukemia patients |
Rinaldi I., Louisa M., Sari R.M., Arwanih E. |
OncoTargets and Therapy |
1 |
Q2 |
|
|
686 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Tpmt genetic variability and its association with hematotoxicity in indonesian children with acute lymphoblastic leukemia in maintenance therapy |
Rosdiana D.S., Setiabudy R., Andalusia R., Gatot D., Louisa M., Bardosono S., Instiaty I. |
Pharmacogenomics and Personalized Medicine |
1 |
Q2 |
|
|
693 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
A mini systematic review: Eucheuma cottonii, a red algae, as a radiosensitizer? |
Putri T.P., Dewi I.A.T.K., Permata T.B.M., Nuryadi E., Kodrat H., Wibowo H., Louisa M., Gondhowiardjo S.A. |
Tropical Journal of Natural Product Research |
|
Q4 |
|
|
707 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Determine Curcumin Concentration in Organ Rats and in Ovaries at Ovarian Cancer Model Rats Using Ultra Performance Liquid Chromatography-Mass Spectrometry (Ms)/Ms |
Sandhiutami N.M.D., Arozal W., Louisa M., Rahmat D. |
Pharmaceutical Sciences Asia |
|
Q3 |
|
|
708 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Immunogenicity and efficacy of insulin glargine biosimilar ezelin versus originator insulin glargine in patients with type 2 diabetes |
Tarigan T.J.E., Dwijayanti A., Setyowati S., Louisa M. |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy |
|
Q2 |
|
|
728 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Development, characterization and pharmacokinetic profile of chitosan-sodium tripolyphosphate nanoparticles based drug delivery systems for curcumin |
Arozal W., Louisa M., Rahmat D., Chendrana P., Sandhiutami N.M.D. |
Advanced Pharmaceutical Bulletin |
1 |
Q1 |
|
|